Machine Learning Models for Screening Steatosis in MASLD: An International Validation Study [0.03%]
基于机器学习的检测MASLD患者肝脂肪变性的筛查模型：一项国际多中心验证研究
Junzhao Ye,Xiongcai Feng,Jiaming Lai et al.
Junzhao Ye et al.
Background and aims: Emerging machine learning models show promise in addressing the unmet needs for the non-invasive screening of metabolic dysfunction-associated steatotic liver disease (MASLD) but lack extensive valida...
Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD: A Cross-Sectional Study From the NHANES Database [0.03%]
循环脂肪酸的定性特性与MASLD相关：来自NHANES数据库的横断面研究
Stefano Ciardullo,Michela Vergani,Mariangela Rizzo et al.
Stefano Ciardullo et al.
Background and objective: The role of circulating fatty acids (FA) as well as the association between their composition and metabolic dysfunction-associated steatotic liver disease (MASLD) is not known. Here, we evaluate ...
Feasibility and Safety of Cytosorb Application in Patients With Acute Liver Failure [0.03%]
细胞吸附技术在急性肝功能衰竭患者中应用的可行性及安全性研究
Haselwanter Patrick,Fairfield Seanna,Reinhold Riva et al.
Haselwanter Patrick et al.
Background and aims: Acute liver failure (ALF) is a rare, life-threatening condition with high mortality and limited therapeutic options beyond liver transplantation. Cytosorb adsorber can be easily applied to continuous ...
Clinical Perspectives on Long-Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain-The ALBA Study [0.03%]
西班牙ALBA研究：终末期肝硬化的长期白蛋白治疗的全国德尔菲调查临床观点
Jose Ignacio Fortea,Diego Rincon Rodríguez,Agustín Albillos et al.
Jose Ignacio Fortea et al.
Background and aims: Albumin is well established for some acute indications in decompensated cirrhosis, but its long-term use remains controversial. The ALBA study explored expert clinical perspectives, barriers, and curr...
Chunfeng Shi,Jingjing Zhang,Wei Wang
Chunfeng Shi
Reply to "Reconsidering Cardiovascular Risk Assessment in Patients With MASLD" [0.03%]
对《重新考虑慢性肾脏病谱系疾病患者心血管风险评估》一文的回信
Tie Xiao,Xiao-Dong Zhou,Ming-Hua Zheng
Tie Xiao
Cynthia Levy,Marlyn J Mayo,C Fiorella Murillo Perez
Cynthia Levy
SIRT5 Facilitates Liver Steatosis Progression via Promoting SDH Desuccinylation During High-Fat Diet Feeding [0.03%]
SIRT5通过促进高脂饮食喂养期间SDH脱琥珀酰化促进肝脂肪变性进展
Zekun Liu,Jie Hu,Yinan Lin et al.
Zekun Liu et al.
Background and aims: Obesity is one of the main factors that causes liver steatosis. While the mechanism remains to be elucidated. Methods: ...
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers [0.03%]
德瓦鲁单抗治疗晚期胆道癌的真实世界数据：来自多家国际中心的大样本报告
Margherita Rimini,Lorenzo Fornaro,Masafumi Ikeda et al.
Margherita Rimini et al.
Background: We recently published the first real-world multicenter and multi-institutional study of cisplatin, gemcitabine, and durvalumab in patients with advanced biliary tract cancer (BTC). Here we present an expanded ...
Authors' Reply to "Reconsidering the Plasma Ammonia Levels in Overt Hepatic Encephalopathy" [0.03%]
致letter《重新考虑明显肝性脑病的血氨水平》作者的回复
Davide Erminelli,Chiara Mangini,Dario Gapeni et al.
Davide Erminelli et al.